Cargando…
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
To inform the level of attention to be given by antiretroviral therapy (ART) programs to HIV drug resistance (HIVDR), we used an individual-level model to estimate its impact on future AIDS deaths, HIV incidence, and ART program costs in sub–Saharan Africa (SSA) for a range of program situations. We...
Autores principales: | Phillips, Andrew N., Stover, John, Cambiano, Valentina, Nakagawa, Fumiyo, Jordan, Michael R., Pillay, Deenan, Doherty, Meg, Revill, Paul, Bertagnolio, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451603/ https://www.ncbi.nlm.nih.gov/pubmed/28329236 http://dx.doi.org/10.1093/infdis/jix089 |
Ejemplares similares
-
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018) -
Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
por: Phillips, Andrew, et al.
Publicado: (2014) -
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2016) -
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2017) -
Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa
por: Phillips, Andrew N, et al.
Publicado: (2016)